Douglas G. Cole Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Douglas G. Cole.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Douglas G. Cole. Douglas G. Cole is Director in AVEO PHARMACEUTICALS INC ($AVEO) and Director in AGIOS PHARMACEUTICALS INC ($AGIO) and Director in Quanterix Corp ($QTRX) and Director in Editas Medicine, Inc. ($EDIT) and Director in Denali Therapeutics Inc. ($DNLI) and Director in Sana Biotechnology, Inc. ($SANA).
Latest Insider Trading Transactions of Douglas G. Cole
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGIO, AVEO, DNLI, EDIT, QTRX, SANA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 04 2021 | DNLI | Denali Therapeutic ... | Cole Douglas G. | Director | Option Exercise | A | 63.76 | 6,222 | 396,715 | 6,222 | |
Jun 04 2021 | DNLI | Denali Therapeutic ... | Cole Douglas G. | Director | Grant | A | 0.00 | 2,074 | 0 | 5,327 | 3.3 K to 5.3 K (+63.76 %) |
Feb 05 2021 | SANA | Sana Biotechnology ... | Cole Douglas G. | Director | Option Exercise | A | 25.00 | 14,000 | 350,000 | 14,000 | |
Jun 05 2020 | DNLI | Denali Therapeutic ... | Cole Douglas G. | Director | Option Exercise | A | 0.00 | 3,253 | 0 | 3,253 | |
Jun 05 2020 | DNLI | Denali Therapeutic ... | Cole Douglas G. | Director | Option Exercise | A | 28.82 | 15,183 | 437,574 | 15,183 | |
May 31 2019 | DNLI | Denali Therapeutic ... | Cole Douglas G. | Director | Option Exercise | A | 19.50 | 27,245 | 531,278 | 27,245 | |
Aug 09 2018 | QTRX | Quanterix Corp | Cole Douglas G. | Director | Option Exercise | A | 14.80 | 7,900 | 116,920 | 7,900 | |
Aug 09 2018 | QTRX | Quanterix Corp | Cole Douglas G. | Director | Grant | A | 0.00 | 2,270 | 0 | 2,270 | 0 to 2.3 K |
Jun 15 2018 | DNLI | Denali Therapeutic ... | Cole Douglas G. | Director | Option Exercise | A | 18.92 | 27,830 | 526,544 | 27,830 | |
Dec 08 2017 | DNLI | Denali Therapeutic ... | Cole Douglas G. | Director | Option Exercise | A | 18.00 | 47,165 | 848,970 | 47,165 | |
Aug 21 2017 | EDIT | Editas Medicine, I ... | Cole Douglas G. | Director | Buy | J | 0.00 | 1,686 | 0 | 3,171 | 1.5 K to 3.2 K (+113.54 %) |
Jun 19 2017 | EDIT | Editas Medicine, I ... | Cole Douglas G. | Director | Option Exercise | A | 15.63 | 11,538 | 180,339 | 11,538 | |
Aug 15 2016 | EDIT | Editas Medicine, I ... | Cole Douglas G. | Director | Buy | J | 0.00 | 1,485 | 0 | 1,485 | 0 to 1.5 K |
Aug 11 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cole Douglas G. | Director | Buy | J | 0.00 | 917 | 0 | 2,778 | 1.9 K to 2.8 K (+49.27 %) |
Jun 23 2016 | AGIO | AGIOS PHARMACEUTIC ... | Cole Douglas G. | Director | Option Exercise | A | 47.33 | 8,000 | 378,640 | 31,125 | |
Jun 25 2015 | AGIO | AGIOS PHARMACEUTIC ... | Cole Douglas G. | Director | Option Exercise | A | 103.63 | 10,625 | 1,101,069 | 23,125 | |
May 16 2011 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 17.98 | 49,500 | 889,876 | 395,565 | 445.1 K to 395.6 K (-11.12 %) |
May 16 2011 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 17.98 | 2,992 | 53,788 | 23,909 | 26.9 K to 23.9 K (-11.12 %) |
May 16 2011 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 17.75 | 76,750 | 1,362,451 | 445,065 | 521.8 K to 445.1 K (-14.71 %) |
May 16 2011 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 17.75 | 4,639 | 82,350 | 26,901 | 31.5 K to 26.9 K (-14.71 %) |
May 16 2011 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 17.30 | 15,200 | 263,010 | 521,815 | 537 K to 521.8 K (-2.83 %) |
May 16 2011 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 17.30 | 919 | 15,902 | 31,540 | 32.5 K to 31.5 K (-2.83 %) |
Jan 03 2011 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.53 | 6,036 | 87,705 | 600,248 | 606.3 K to 600.2 K (-1.00 %) |
Jan 03 2011 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.53 | 364 | 5,289 | 33,286 | 33.7 K to 33.3 K (-1.08 %) |
Jan 03 2011 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.56 | 18,384 | 267,605 | 606,284 | 624.7 K to 606.3 K (-2.94 %) |
Jan 03 2011 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.56 | 1,109 | 16,143 | 33,650 | 34.8 K to 33.7 K (-3.19 %) |
Jan 03 2011 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.62 | 6,130 | 89,628 | 624,668 | 630.8 K to 624.7 K (-0.97 %) |
Jan 03 2011 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.62 | 370 | 5,410 | 34,759 | 35.1 K to 34.8 K (-1.05 %) |
Dec 29 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.50 | 13,308 | 192,922 | 630,798 | 644.1 K to 630.8 K (-2.07 %) |
Dec 29 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.50 | 804 | 11,655 | 35,129 | 35.9 K to 35.1 K (-2.24 %) |
Dec 29 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.62 | 9,180 | 134,239 | 644,106 | 653.3 K to 644.1 K (-1.41 %) |
Dec 29 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.62 | 555 | 8,116 | 35,933 | 36.5 K to 35.9 K (-1.52 %) |
Dec 27 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.53 | 8,672 | 126,018 | 653,286 | 662 K to 653.3 K (-1.31 %) |
Dec 27 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.53 | 524 | 7,615 | 36,488 | 37 K to 36.5 K (-1.42 %) |
Dec 27 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.60 | 4,493 | 65,604 | 661,958 | 666.5 K to 662 K (-0.67 %) |
Dec 27 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.60 | 272 | 3,972 | 37,012 | 37.3 K to 37 K (-0.73 %) |
Dec 22 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.68 | 16,503 | 242,285 | 666,451 | 683 K to 666.5 K (-2.42 %) |
Dec 22 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.68 | 997 | 14,637 | 37,284 | 38.3 K to 37.3 K (-2.60 %) |
Dec 22 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.29 | 13,956 | 199,405 | 682,954 | 696.9 K to 683 K (-2.00 %) |
Dec 22 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.29 | 844 | 12,059 | 38,281 | 39.1 K to 38.3 K (-2.16 %) |
Dec 21 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.11 | 19,332 | 272,807 | 696,910 | 716.2 K to 696.9 K (-2.70 %) |
Dec 21 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.11 | 1,168 | 16,482 | 39,125 | 40.3 K to 39.1 K (-2.90 %) |
Dec 21 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.07 | 10,891 | 153,209 | 716,242 | 727.1 K to 716.2 K (-1.50 %) |
Dec 21 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.07 | 658 | 9,256 | 40,293 | 41 K to 40.3 K (-1.61 %) |
Dec 17 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.21 | 10,851 | 154,205 | 727,133 | 738 K to 727.1 K (-1.47 %) |
Dec 17 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.21 | 656 | 9,322 | 40,951 | 41.6 K to 41 K (-1.58 %) |
Dec 17 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.14 | 6,978 | 98,661 | 737,984 | 745 K to 738 K (-0.94 %) |
Dec 17 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.14 | 422 | 5,967 | 41,607 | 42 K to 41.6 K (-1.00 %) |
Dec 15 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.06 | 10,278 | 144,503 | 744,962 | 755.2 K to 745 K (-1.36 %) |
Dec 15 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.06 | 622 | 8,745 | 42,029 | 42.7 K to 42 K (-1.46 %) |
Dec 15 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.54 | 9,996 | 145,337 | 755,240 | 765.2 K to 755.2 K (-1.31 %) |
Dec 15 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.54 | 604 | 8,782 | 42,651 | 43.3 K to 42.7 K (-1.40 %) |
Dec 13 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.47 | 8,581 | 124,188 | 765,236 | 773.8 K to 765.2 K (-1.11 %) |
Dec 13 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.47 | 519 | 7,511 | 43,255 | 43.8 K to 43.3 K (-1.19 %) |
Dec 13 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.39 | 7,921 | 114,016 | 773,817 | 781.7 K to 773.8 K (-1.01 %) |
Dec 13 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.39 | 479 | 6,895 | 43,774 | 44.3 K to 43.8 K (-1.08 %) |
Dec 09 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.93 | 25,838 | 385,772 | 781,738 | 807.6 K to 781.7 K (-3.20 %) |
Dec 09 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.93 | 1,562 | 23,321 | 44,253 | 45.8 K to 44.3 K (-3.41 %) |
Dec 09 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.93 | 5,935 | 88,621 | 807,576 | 813.5 K to 807.6 K (-0.73 %) |
Dec 09 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.93 | 359 | 5,361 | 45,815 | 46.2 K to 45.8 K (-0.78 %) |
Dec 07 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.92 | 13,674 | 204,054 | 799,837 | 813.5 K to 799.8 K (-1.68 %) |
Dec 07 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.92 | 827 | 12,341 | 45,347 | 46.2 K to 45.3 K (-1.79 %) |
Dec 07 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.90 | 19,706 | 293,686 | 813,511 | 833.2 K to 813.5 K (-2.37 %) |
Dec 07 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.90 | 1,192 | 17,765 | 46,174 | 47.4 K to 46.2 K (-2.52 %) |
Dec 03 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.50 | 25,979 | 376,631 | 833,217 | 859.2 K to 833.2 K (-3.02 %) |
Dec 03 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 14.50 | 1,571 | 22,776 | 47,366 | 48.9 K to 47.4 K (-3.21 %) |
Dec 03 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 15.02 | 10,278 | 154,389 | 859,196 | 869.5 K to 859.2 K (-1.18 %) |
Dec 03 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Sell | S | 15.02 | 622 | 9,343 | 48,937 | 49.6 K to 48.9 K (-1.26 %) |
Jun 25 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Option Exercise | A | 7.44 | 12,500 | 93,000 | 12,500 | |
Mar 18 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Option Exercise | C | 0.00 | 378,126 | 0 | 0 | |
Mar 18 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Option Exercise | C | 0.00 | 2,901,538 | 0 | 0 | |
Mar 18 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Option Exercise | C | 0.00 | 22,855 | 0 | 0 | |
Mar 18 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Option Exercise | C | 0.00 | 175,385 | 0 | 0 | |
Mar 18 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Buy | C | 0.00 | 94,531 | 0 | 869,474 | 774.9 K to 869.5 K (+12.20 %) |
Mar 18 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Buy | C | 0.00 | 725,384 | 0 | 774,943 | 49.6 K to 774.9 K (+1,463.68 %) |
Mar 18 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Buy | C | 0.00 | 5,713 | 0 | 49,559 | 43.8 K to 49.6 K (+13.03 %) |
Mar 18 2010 | AVEO | AVEO PHARMACEUTICA ... | Cole Douglas G. | Director | Buy | C | 0.00 | 43,846 | 0 | 43,846 | 0 to 43.8 K |
Page: 1